Pharmaceutical manufacturing in New York comprises a vibrant array of companies dedicated to producing essential drugs and therapies. This industry is not only pivotal for patient health but also stands as a vital part of the local economy. With companies ranging from multinationals to specialized biopharmaceuticals, the sector includes firms focused on generic drugs, over-the-counter products, and complex injectables. As the industry adapts to trends like biosimilars and personalized medicine, New York-based manufacturers innovate to meet challenges such as regulatory pressures and supply chain dynamics, ensuring that healthcare providers have access to reliable and affordable treatments.

The pharmaceutical manufacturing sector in New York boasts 25 notable companies, varied by size, founding year, and specialization. From organizations like Par Pharmaceutical and PL Developments to newer entrants like Ichnos Sciences, these firms produce an array of drug forms, predominantly focusing on generics and niche products. Headquartered across the state in locales from Chestnut Ridge to Hauppauge, these companies collectively employ thousands and demonstrate a commitment to quality and compliance, reflecting the dynamic evolution of the pharmaceutical manufacturing landscape in the region.

Read on to discover the top pharmaceutical manufacturing companies in New York.

Top 25 Pharmaceutical Manufacturing Companies in New York

1. Par Pharmaceutical

• Website: parpharm.com
• Ownership type: Corporate
• Headquarters: Chestnut Ridge, New York, United States (USA)
• Employee distribution: India 57%, United States (USA) 42%
• Latest funding: $8.1B, May 2015
• Founded year: 1978
• Headcount: 501-1000
• LinkedIn: par-pharmaceutical

Par Pharmaceutical, a subsidiary of Endo International, is based in Chestnut Ridge, New York. Founded in 1978, the company specializes in developing and delivering therapies that enhance patient health across multiple medical fields, including urology, orthopedics, and pediatric endocrinology. Par Pharmaceutical is known for its focus on specialty medicines, sterile injectables, and generic products, catering to healthcare providers, hospitals, and patients. The company operates a significant manufacturing network, which includes a new facility in Rochester, Michigan, aimed at supporting future innovations in medicine. With a workforce of approximately 1,415 employees, Par Pharmaceutical is dedicated to improving health outcomes through its extensive product offerings and commitment to quality in manufacturing.

2. PL Developments

• Website: pldevelopments.com
• Ownership type: Family Owned
• Headquarters: Westbury, New York, United States (USA)
• Employee distribution: United States (USA) 99%, Other 1%
• Latest funding: Other (Debt), $500.0M, October 2024
• Founded year: 1988
• Headcount: 1001-5000
• LinkedIn: pl-developments

PL Developments, based in Westbury, New York, is a family-owned pharmaceutical manufacturer that has been operational since 1988. The company specializes in the development and production of over-the-counter health and beauty products, catering to both major retailers and consumers. Their product offerings include allergy medications, analgesics, cough and cold remedies, digestive aids, feminine care products, first aid items, personal care solutions, nicotine replacement therapies, and sleep aids. PL Developments prides itself on maintaining high standards of quality and regulatory compliance, ensuring that their products meet the stringent requirements set by the FDA. The company also engages in contract manufacturing and packaging for other brands, further solidifying its role in the pharmaceutical landscape. Recently, PL Developments secured $500 million in funding, which underscores their commitment to growth and innovation in the industry.

3. Epic Pharma

• Website: epic-pharma.com
• Ownership type: Corporate
• Headquarters: Queens, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $550.0M, March 2016
• Founded year: 2008
• Headcount: 201-500
• LinkedIn: epic-pharma

Epic Pharma, LLC, founded in 2008, is a pharmaceutical manufacturer based in Queens, New York. The company focuses on developing and producing generic prescription drugs, catering to healthcare providers and pharmacies. Epic Pharma operates a state-of-the-art, FDA-approved manufacturing facility that spans 110,000 square feet and employs approximately 200 individuals. Their product offerings include medications in tablet, capsule, and powder forms, covering various therapeutic categories. In addition to their internal drug development, Epic Pharma also provides contract manufacturing services, emphasizing quality and cost-effectiveness. The company has established itself as a significant player in the generic pharmaceuticals market, contributing to the accessibility of essential medications.

4. Contract Pharmacal Corp

• Website: cpc.com
• Ownership type: Private
• Headquarters: Hauppauge, New York, United States (USA)
• Employee distribution: United States (USA) 84%, India 16%
• Founded year: 1971
• Headcount: 1001-5000
• LinkedIn: contract-pharmacal-corp

Contract Pharmacal Corp (CPC), based in Hauppauge, New York, is a private contract manufacturer and pharmaceutical developer that has been operational since 1971. The company specializes in the production of over-the-counter drugs and dietary supplements, serving a range of clients from major pharmaceutical firms to retail brands. With a workforce of approximately 335 employees, CPC prides itself on its rigorous quality assurance processes and its ability to navigate complex regulatory landscapes. The company has developed over 5,000 unique formulas and boasts an annual solid-dose capacity of 25 billion doses. CPC is recognized for its innovative approach to manufacturing and product development, ensuring that clients can bring their products to market efficiently and effectively. Their facilities are equipped with state-of-the-art technology, allowing for a variety of dosage forms, including tablets, capsules, and powders. CPC also emphasizes community involvement and environmental responsibility, reflecting a commitment to corporate social responsibility alongside their business operations.

5. American Regent, Inc.

• Website: americanregent.com
• Ownership type: Private
• Headquarters: Shirley, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1910
• Headcount: 501-1000
• LinkedIn: americanregent

American Regent, Inc., founded in 1910 and based in Shirley, New York, is a private pharmaceutical company that specializes in the manufacturing and distribution of injectable medications. With a workforce of approximately 852 employees, the company plays a crucial role in supplying healthcare providers and institutions with essential products that are vital for patient care. American Regent is particularly focused on addressing drug shortages, collaborating with the FDA to mitigate these issues. Their product portfolio includes a range of FDA-approved injectable medications, such as Sodium Phosphates Injection and Epinephrine Injection. In addition to their core offerings, American Regent has expanded its reach into the oncology market through a partnership with HBT Labs. The company has also been recognized for its excellence in healthcare performance improvement, receiving the 2023 Novaplus Program Excellence Award from Vizient, Inc.

6. Steri-Pharma LLC

• Website: steri-pharma.com
• Ownership type: Private
• Headquarters: Syracuse, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2008
• Headcount: 51-200
• LinkedIn: steri-pharmallc

Steri-Pharma LLC, based in Syracuse, New York, is a private pharmaceutical manufacturer that specializes in sterile antibiotics. Founded in 2008, the company has built a reputation for quality and reliability, serving healthcare providers and pharmaceutical distributors. Steri-Pharma operates a manufacturing facility that spans over 70,000 square feet, which includes areas dedicated to production, quality control, and office space. The company is committed to maintaining high standards of safety and efficacy in its products, adhering to both national and international regulatory requirements. Recently, Steri-Pharma announced plans for a significant expansion of its plant, which will more than double its workforce, reflecting its growth strategy and commitment to meeting the increasing demand for antibiotics. With approvals in 40 countries, Steri-Pharma is positioned to serve a global market, emphasizing its role in the pharmaceutical manufacturing sector.

7. LNK International Inc.

• Website: lnkintl.com
• Ownership type: Private
• Headquarters: Hauppauge, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1980
• Headcount: 1001-5000
• LinkedIn: lnk-international-inc.

LNK International Inc., based in Hauppauge, New York, is a pharmaceutical manufacturer that specializes in over-the-counter (OTC) products. Established in 1980, the company has built a reputation for delivering high-quality medications, including pain relief, gastrointestinal products, and cold and allergy treatments. LNK International primarily serves retailers, such as drug and supermarket chains, helping them enhance their store brand programs. The company operates multiple facilities where they manufacture both solid and liquid dose pharmaceuticals. With a commitment to quality, LNK employs lab chemists who rigorously test every batch, ensuring that their products meet high standards. Their extensive product line includes over 170 national brand equivalent formulas, reflecting their significant role in the OTC market. LNK International also offers packaging and marketing services, further supporting their clients in optimizing product offerings and enhancing consumer appeal.

8. BOC Sciences

• Website: bocsci.com
• Ownership type: Private
• Headquarters: Shirley, New York, United States (USA)
• Employee distribution: United States (USA) 67%, Iraq 33%
• Founded year: 2005
• Headcount: 501-1000
• LinkedIn: boc-sciences

BOC Sciences, founded in 2005 and based in Shirley, New York, is a private chemical manufacturer that specializes in high-quality chemical production and research and development services. The company primarily serves pharmaceutical and biotechnology firms, offering a broad range of products that support drug discovery and life sciences. Their product lineup includes small-molecule inhibitors, pharmaceutical excipients, and various intermediates, which are essential for drug development. BOC Sciences also provides custom synthesis services and operates under cGMP guidelines, ensuring compliance with industry standards. Their commitment to innovation is evident through their participation in industry conferences, where they engage with professionals to discuss advancements in drug discovery projects. With a workforce that includes a significant percentage of employees based in the USA, BOC Sciences is positioned to meet the needs of its clients effectively.

9. United Biomedical, Inc. (UBI)

• Website: unitedbiomedical.com
• Ownership type: Private
• Headquarters: Hauppauge, New York, United States (USA)
• Employee distribution: Taiwan 60%, United States (USA) 40%
• Founded year: 1985
• Headcount: 11-50
• LinkedIn: united-biomedical-inc.-ubi-

United Biomedical, Inc. (UBI), founded in 1985 and based in Hauppauge, New York, is a private biopharmaceutical company dedicated to the development of diagnostics and immunotherapeutics. With a workforce of approximately 45 employees, UBI operates primarily in the human and animal health sectors. The company has made significant strides in the industry, being recognized for pioneering the world’s first peptide-based diagnostic test and the first fully synthetic peptide-based vaccine. UBI's product offerings include vaccines, specialty injectables, and a range of diagnostic tools, catering to healthcare providers and pharmaceutical companies seeking innovative health solutions. Their operations extend across multiple therapeutic areas, including neurology, immunology, and infectious diseases. UBI collaborates with global firms and has a notable presence in Asia, particularly Taiwan, where a significant portion of their workforce is located. Their commitment to research and development is evident in their extensive product pipeline, which includes advancements in vaccine technology and antibody diagnostics.

10. ScieGen Pharmaceuticals Inc

• Website: sciegenpharm.com
• Ownership type: Private
• Headquarters: Hauppauge, New York, United States (USA)
• Employee distribution: United States (USA) 84%, India 16%
• Founded year: 2010
• Headcount: 201-500
• LinkedIn: sciegen-pharmaceuticals-inc

ScieGen Pharmaceuticals Inc, founded in 2010 and based in Hauppauge, New York, is a private pharmaceutical company that specializes in the development, manufacturing, and distribution of generic pharmaceutical products. The company is dedicated to providing high-quality and cost-effective medications to healthcare providers and patients, ensuring that essential drugs are accessible. ScieGen operates state-of-the-art manufacturing facilities in the United States, adhering to current Good Manufacturing Practices (cGMP). With a strong emphasis on quality assurance and regulatory compliance, ScieGen has successfully filed over 60 Abbreviated New Drug Applications (ANDAs), showcasing their active role in the pharmaceutical market. The company also maintains a research and development facility in India, further enhancing its capabilities in product development and innovation. ScieGen's commitment to safety and quality is reflected in their recent ANDA approvals for various medications, demonstrating their ongoing contribution to the pharmaceutical industry.

11. Abon Pharmaceuticals, LLC

• Website: abonpharma.com
• Ownership type: Private
• Headquarters: Chestnut Ridge, New York, United States (USA)
• Employee distribution: United States (USA) 89%, United Kingdom (UK) 5%, Portugal 5%
• Founded year: 2009
• Headcount: 11-50
• LinkedIn: abon-pharmaceuticals-llc

Abon Pharmaceuticals, LLC is a specialty pharmaceutical company based in Chestnut Ridge, New York, established in 2009. The company specializes in the development of complex generics and proprietary products, particularly in injectable and oral dosage forms. Abon is dedicated to enhancing drug delivery through rigorous research and modern manufacturing techniques. Their team of scientists has a proven track record in pharmaceutical product development, generating multiple patents along the way. Abon serves a range of clients, including healthcare providers and other pharmaceutical companies, by providing innovative drug solutions that prioritize product quality and patient compliance. Recently, Abon received FDA approval for its ANDA for a generic version of Carafate® (sucralfate) oral suspension, which is set to launch soon. This approval reflects their capability to develop products that meet market needs and regulatory standards.

12. Chartwell Pharmaceuticals

• Website: chartwellpharma.com
• Ownership type: Private
• Headquarters: Congers, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2010
• Headcount: 51-200
• LinkedIn: chartwell-pharmaceuticals

Chartwell Pharmaceuticals LLC is a pharmaceutical company based in Congers, New York, that specializes in the development and manufacturing of generic medications. Established in 2010, the company aims to serve healthcare providers and organizations by offering a wide range of affordable pharmaceutical products, ensuring that patient care remains accessible. Chartwell operates through strategic partnerships and is focused on enhancing its product pipeline, which includes over 700 Orange Book listings. The company is actively pursuing product acquisitions and has a commitment to expanding its capabilities in various dosage forms. With a dedicated leadership team boasting extensive experience in the generic pharmaceutical industry, Chartwell is well-positioned to meet the evolving needs of the market. Their operations are entirely based in the United States, reinforcing their commitment to domestic manufacturing.

13. Woodstock Sterile Solutions

• Website: woodstocksterilesolutions.com
• Ownership type: Corporate
• Headquarters: Woodstock, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: March 2023
• Founded year: 1968
• Headcount: 501-1000
• LinkedIn: woodstock-sterile-solutions

Woodstock Sterile Solutions, founded in 1968 and based in Woodstock, New York, is a contract development and manufacturing organization (CDMO) that specializes in aseptic pharmaceutical manufacturing. The company has built a strong reputation for its advanced blow-fill-seal technology, which is utilized for the production of sterile liquid formulations. Woodstock Sterile Solutions supports healthcare companies in developing and producing complex formulations and biologics, ensuring that their products meet stringent quality and regulatory standards. With a workforce of around 168 employees, the company operates entirely within the United States and has a proven track record of helping clients navigate the complexities of pharmaceutical manufacturing. Their services include formulation development, clinical supply, and lifecycle management, making them a reliable partner for pharmaceutical firms looking to bring innovative products to market.

14. XGen Pharmaceuticals DJB

• Website: xgenpharmadjb.com
• Ownership type: Family Owned
• Headquarters: Big Flats, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2003
• Headcount: 51-200
• LinkedIn: x-gen-pharmaceuticals-inc

XGen Pharmaceuticals DJB, Inc. is a pharmaceutical company based in Big Flats, New York, specializing in the manufacturing and distribution of generic medications. Established in 2003, the company has roots that date back to 1972, when it was founded by Dan Badia. With a workforce of approximately 62 employees, XGen focuses on injectable pharmaceuticals, catering to healthcare providers, hospitals, and pharmacies. Their mission is to provide affordable medications that enhance and save lives, reflecting a commitment to quality and compliance in the pharmaceutical sector. The company has made significant strides in ensuring regulatory compliance, having received accreditation from the National Association of Boards of Pharmacy in May 2022. XGen's product offerings include a range of injectable medications, showcasing their expertise in this niche market. They actively participate in industry events and maintain a focus on building meaningful relationships within the pharmaceutical community.

15. Igi

• Website: iginnovate.com
• Ownership type: Private
• Headquarters: New York, New York, United States (USA)
• Employee distribution: Switzerland 75%, United States (USA) 16%, India 9%
• Founded year: 2019
• Headcount: 51-200
• LinkedIn: ichnos-sciences

Ichnos Glenmark Innovation (IGI) is a biotechnology firm based in New York, founded in 2019. The company is dedicated to developing innovative therapies aimed at treating cancer, particularly focusing on hematological malignancies and solid tumors. IGI operates with a strong pipeline of therapies currently in various stages of clinical development, including several in Phase 1 trials. Their approach combines internal expertise with external collaborations, allowing them to push the boundaries of cancer treatment. The company has established state-of-the-art centers of innovation in the USA, Switzerland, and India, which facilitate their research and development efforts. With a team of approximately 150 employees, IGI is committed to creating cutting-edge solutions that offer new hope to patients and healthcare professionals alike.

16. A&Z Pharmaceutical, Inc.

• Website: azpharmaceutical.com
• Ownership type: Private
• Headquarters: Hauppauge, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1995
• Headcount: 201-500
• LinkedIn: a%26z-pharmaceuticals

A&Z Pharmaceutical, Inc., based in Hauppauge, New York, is a private pharmaceutical manufacturer established in 1995. With a workforce of approximately 482 employees, the company specializes in the production of dietary supplements, particularly calcium products. A&Z is dedicated to improving health outcomes through rigorous research, development, and manufacturing processes. Their state-of-the-art facilities are designed to meet high-quality standards, and they are recognized for their commitment to safety and efficacy in product development. A&Z's flagship product, D-Cal, is the top pharmacist-recommended calcium supplement in China and ranks among the best-selling products in Asia. The company operates a 175,000 square foot facility that supports a wide range of pharmaceutical manufacturing needs, from formulation development to packaging. A&Z Pharmaceutical is positioned as a trusted partner for businesses seeking high-quality health solutions, with a strong emphasis on innovation and customer satisfaction.

17. Saptalis Pharmaceuticals,LLC

• Website: saptalis.com
• Ownership type: Private
• Headquarters: Hauppauge, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $6.5M, November 2016
• Founded year: 2015
• Headcount: 11-50
• LinkedIn: saptalis-pharmaceutcals-llc

Saptalis Pharmaceuticals, LLC is a pharmaceutical company based in Hauppauge, New York, specializing in the development, manufacturing, and commercialization of niche generic and innovative products. Founded in 2015, Saptalis has built a reputation for providing high-quality, affordable medicines that cater to specific medical needs. The company operates state-of-the-art facilities that meet FDA cGMP requirements, ensuring that their products are manufactured to the highest standards. Saptalis has developed a growing portfolio of FDA-approved prescription products, including recent launches like Lithium Oral Solution and Hydrocortisone and Acetic Acid Otic Solution. Their focus on utilizing ANDA and 505(b)(2) regulatory pathways demonstrates their commitment to innovation and responsiveness to market demands. With a dedicated team and a robust pipeline, Saptalis is positioned to continue contributing to the pharmaceutical sector.

18. Ichnos Sciences

• Website: ichnossciences.com
• Ownership type: Private
• Headquarters: New York, New York, United States (USA)
• Founded year: 2019
• Headcount: 51-200
• LinkedIn: ichnos-sciences

Ichnos Sciences, also known as Ichnos Glenmark Innovation, is a biotechnology and pharmaceutical company based in New York, USA. Founded in 2019, the company is dedicated to developing innovative therapy solutions specifically targeting hematological malignancies and solid tumors. Ichnos Sciences operates with a robust pipeline that includes several products currently in Phase 1 clinical trials, such as ISB 1442 and ISB 2001, which are designed to engage immune cells in the treatment of cancer. The company collaborates with healthcare professionals and organizations to enhance treatment options and improve patient outcomes in oncology. With state-of-the-art research centers located in the USA, Switzerland, and India, Ichnos Sciences leverages a proprietary protein engineering platform to create multispecific antibodies, showcasing their commitment to advancing cancer therapies. Their leadership team brings extensive experience in drug development and immuno-oncology, further solidifying their position in the pharmaceutical industry.

19. Gyma Laboratories Inc.

• Website: gyma.com
• Ownership type: Private
• Headquarters: Woodbury, New York, United States (USA)
• Employee distribution: United States (USA) 58%, India 28%, China 14%
• Founded year: 1953
• Headcount: 11-50
• LinkedIn: gyma-laboratories-of-america-inc-

Gyma Laboratories Inc. is a pharmaceutical service provider based in Woodbury, New York, with a history dating back to 1951. The company specializes in drug development and manufacturing, offering a comprehensive suite of services that includes the production of active pharmaceutical ingredients (APIs), contract development and manufacturing organization (CDMO) services, and regulatory affairs support. Gyma's expertise allows them to assist pharmaceutical companies in navigating the complexities of drug development, ensuring compliance with industry regulations, and facilitating successful product launches. With a workforce of approximately 36 employees, Gyma operates globally, with a significant presence in the United States, India, and China. Their commitment to ethical practices, transparent communication, and customer-centric solutions has established them as a trusted partner in the pharmaceutical industry. Gyma's extensive experience and dedication to innovation enable them to support a wide array of therapeutic applications, making healthcare more accessible and affordable worldwide.

20. Sanavia Oncology Inc.

• Website: sanavia.bio
• Ownership type: Private
• Headquarters: New York, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2020
• Headcount: 11-50
• LinkedIn: sanavia-oncology

Sanavia Oncology Inc. is a New York-based biotechnology firm founded in 2020, dedicated to the development of innovative immunotherapies to combat drug-resistant cancer. The company is staffed by a team of drug developers with backgrounds from prestigious institutions such as Memorial Sloan-Kettering Cancer Center, Rockefeller University, Weill Cornell Medicine, and Columbia University. Sanavia's mission centers on improving patient outcomes by addressing the limitations of current cancer therapies, particularly for patients who do not respond to existing treatments due to drug resistance. They employ advanced scientific techniques, including high throughput sequencing and artificial intelligence, to validate targets and develop their immunotherapies. Their proprietary discovery platform focuses on identifying clinically relevant, cancer-specific epitopes in drug-resistant tumors, aiming to create antibodies with high specificity. Sanavia actively seeks partnerships with healthcare professionals and organizations to drive innovation in oncology and transform cancer treatment.

21. Jerome Stevens Pharmaceuticals, Inc.

• Website: jeromestevens.com
• Ownership type: Family Owned
• Headquarters: Bohemia, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1976
• Headcount: 51-200
• LinkedIn: jspinc

Jerome Stevens Pharmaceuticals, Inc. is a family-owned pharmaceutical manufacturer based in Bohemia, New York. Established in 1976, the company has carved a niche in the production of prescription medications, with a strong emphasis on quality and safety. Notably, JSP is recognized for its flagship products, Unithroid and Digoxin, which are essential in managing hypothyroidism and heart failure, respectively. The company made history in 2000 by becoming the first to receive FDA approval for Unithroid, establishing it as a reference drug in its category. JSP has a rich history of navigating the complexities of pharmaceutical manufacturing, transitioning from over-the-counter products to prescription medications. Their commitment to quality is underscored by their adherence to stringent manufacturing practices and their focus on producing superior products. Operating exclusively within the United States, JSP continues to prioritize safety and quality, ensuring that their products meet the highest standards in the industry.

22. Gemini Pharmaceuticals, Inc.

• Website: geminipharm.com
• Ownership type: Corporate
• Headquarters: Commack, New York, United States (USA)
• Employee distribution: United States (USA) 95%, Nigeria 5%
• Latest funding: January 2023
• Founded year: 1987
• Headcount: 201-500
• LinkedIn: gemini-pharmaceuticals-inc

Gemini Pharmaceuticals, Inc., based in Commack, New York, has been a significant player in the contract manufacturing sector since its inception in 1987. The company specializes in the production of dietary supplements and over-the-counter (OTC) pharmaceuticals, offering a comprehensive suite of services that includes capsule and tablet manufacturing, product development, and rigorous quality testing. Gemini operates in facilities that are registered with both the FDA and Health Canada, ensuring that their products meet high safety and efficacy standards. The company prides itself on its state-of-the-art analytical laboratory, which is ISO 17025 accredited, underscoring its commitment to quality and compliance. Gemini serves a variety of clients in the dietary supplement and pharmaceutical industries, focusing on delivering high-quality, compliant products. Their operational practices also reflect a commitment to sustainability, employing environmentally conscious methods throughout their manufacturing processes. This dedication to quality and innovation positions Gemini as a noteworthy entity in the pharmaceutical manufacturing landscape.

23. Liptis Usa

• Website: liptisusa.net
• Ownership type: Private
• Headquarters: Spring Valley, New York, United States (USA)
• Employee distribution: Egypt 83%, Libya 11%, Saudi Arabia 3%, Other 3%
• Founded year: 1995
• Headcount: 201-500
• LinkedIn: liptis-usa

Liptis USA, based in Spring Valley, New York, is a private pharmaceutical company established in 1995. The company specializes in the production of pharmaceutical and nutraceutical products aimed at enhancing human health and well-being. Their notable offerings include JointGuard and Stamigen, which target conditions like osteoarthritis. Liptis USA serves a clientele that includes healthcare professionals and patients seeking effective treatment options. The company has a significant presence in international markets, with a workforce that is predominantly located in Egypt, indicating a strong operational footprint outside the United States. Liptis USA is committed to quality and ethical practices in its production processes, ensuring compliance with applicable laws and regulations. They actively participate in industry conferences, which reflects their engagement with the broader pharmaceutical community and their dedication to advancing healthcare solutions.

24. Codagenix Inc.

• Website: codagenix.com
• Ownership type: Venture Capital
• Headquarters: Farmingdale, New York, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Grant), $5.9M, October 2023
• Founded year: 2011
• Headcount: 11-50
• LinkedIn: codagenix

Codagenix Inc., based in Farmingdale, New York, is a biotechnology firm founded in 2011. The company specializes in the development of vaccines and viral therapeutics aimed at combating infectious diseases and cancer. Codagenix employs a unique synthetic biology-driven platform that utilizes codon deoptimization technology to create live-attenuated vaccines. This method allows for rapid development and manufacturing of vaccine candidates, which is crucial in responding to global health threats. Their pipeline includes candidates for COVID-19, RSV, and various cancers, showcasing their focus on innovative solutions. Recently, Codagenix secured $5.88 million in funding, reflecting investor confidence in their approach and potential impact in the healthcare sector. The company collaborates with organizations like the World Health Organization to enhance vaccine accessibility worldwide, further solidifying its role in the pharmaceutical manufacturing industry.

25. Leadermed Health Group Limited

• Website: leadermedgroup.com
• Ownership type: Private
• Headquarters: New York, New York, United States (USA)
• Employee distribution: China 75%, Georgia 12%, United States (USA) 12%
• Founded year: 2020
• Headcount: 11-50
• LinkedIn: leadermed-health-group-limited

Leadermed Health Group Limited is a pharmaceutical development company based in New York, with significant operations in China and Singapore. Founded in 2020, the company specializes in drug development and clinical research services, focusing on innovative medications for pressing health issues such as diabetes and hemophilia. With a dedicated team that has led numerous clinical trials and successfully navigated regulatory approvals, Leadermed is positioned to accelerate the introduction of new drugs in the Asia-Pacific market. Their pipeline includes promising candidates like LM008, a long-acting anti-diabetic drug, and LM007, a treatment for hemophilia. The company collaborates with other pharmaceutical entities to enhance its research and development efforts, aiming to meet the substantial medical needs in the region. Leadermed's commitment to advancing healthcare solutions is evident in its strategic partnerships and its proactive approach to clinical development.

Pharmaceutical Manufacturing Insights: Key Companies in New York

Want to Find More Pharmaceutical Manufacturing Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!